Survey on Epidemiology of Hypoparathyroidism in France
Launched by EUROPEAN GEORGES POMPIDOU HOSPITAL · Jul 17, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Survey on Epidemiology of Hypoparathyroidism in France" aims to gather important information about hypoparathyroidism, a condition that can lead to various health issues. Currently, there is very little data available about how common this condition is in France, and this study seeks to fill that gap. Researchers want to learn more about how many people are affected, what treatments they receive, and any complications they may experience because of the condition.
To participate in this trial, individuals must have been diagnosed with chronic hypoparathyroidism and must live in France. The study is open to all genders and is currently recruiting participants. Those who choose to join will help researchers understand more about this condition, which could lead to better care and treatment options in the future. It’s important to note that individuals who do not wish to have their data collected, or who have related conditions like pseudo-hypoparathyroidism or acute hypoparathyroidism, will not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patient fro whom chronic hypoparathyroidism is diagnosed
- • patient living in France
- Exclusion Criteria:
- • patient who does not want his data to be collected in this registry
- • pseudo-hypoparathyroidism
- • acute hypoparathyroidism
About European Georges Pompidou Hospital
The European Georges Pompidou Hospital (Hôpital Européen Georges-Pompidou, HEGP) is a leading healthcare institution located in Paris, France, dedicated to providing high-quality medical care and advancing medical research. As a prominent clinical trial sponsor, HEGP is committed to facilitating innovative research initiatives that enhance patient outcomes and contribute to the global medical community. With a multidisciplinary approach, HEGP collaborates with renowned researchers and healthcare professionals to conduct clinical trials across various therapeutic areas, ensuring adherence to rigorous ethical standards and regulatory compliance. The hospital's state-of-the-art facilities and expertise in patient care position it as a key player in the advancement of medical science and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dijon, , France
Nantes, , France
Tours, , France
Amiens, , France
Le Mans, , France
Bordeaux, , France
Reims, , France
La Roche Sur Yon, , France
Rouen, , France
Saint Denis, La Réunion, France
Aix En Provence, , France
Auch, , France
Aurillac, , France
Besançon, , France
Bobigny, , France
Bondy, , France
Bourgoin Jallieu, , France
Brest, , France
Caen, , France
Créteil, , France
Dax, , France
Grenoble, , France
Le Kremlin Bicêtre, , France
Libourne, , France
Lille, , France
Lyon, , France
Marseille, , France
Metz, , France
Metz, , France
Montpellier, , France
Mérignac, , France
Nancy, , France
Nice, , France
Niort, , France
Nîmes, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Poitiers, , France
Quimper, , France
Rennes, , France
Saint Junien, , France
Saint Ouen, , France
Strasbourg, , France
Toulon, , France
Toulouse, , France
Tourcoing, , France
Valenciennes, , France
Villeneuve Saint Georges, , France
Blanquefort, , France
Paris, , France
Passy, , France
Saint Florent Le Vieil, , France
Saint Denis, , France
Patients applied
Trial Officials
Jean-Philippe Bertocchio, MD, PhD
Principal Investigator
European Georges Pompidou Hospital, APHP
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials